Startups
A company founded to advance MEMS as a sterile, live-cell sorting platform for cell therapy and cancer diagnostics. Owl biomedical, Inc. is owned by Miltenyi Biotec GmbH, a world leader in cell isolation for therapeutics and innovative research. The Owl biomedical MEMS sorting chip is at the heart of Miltenyi's flagship product, the MACSQuant Tyto. It is truly a revolution in sorting brought about by its inherent gentleness, sterility, and unparalleled ease-of-use.
Overview
Location
United States, California, Goleta
Employees
11-50
Total raised
$3M
Founded date
2011
FAQ about Owl biomedical, Inc.
When was Owl biomedical, Inc. founded?
Owl biomedical, Inc. was founded in 2011.
How much funding has Owl biomedical, Inc. raised?
Owl biomedical, Inc. has raised $3M in total across 1 funding round.
Is Owl biomedical, Inc. still active?
Yes, Owl biomedical, Inc. is active; its latest activity on Parsers VC dates from Feb 17, 2012.